Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites
about
Use of terbinafine in mouse and rat models of Pneumocystis carinii pneumonia.In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin BDetermination of terbinafine in tissues.Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans.Terbinafine, a unique oral antifungal: current perceptions.In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafineIn vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azolesClinical hepatotoxicity associated with antifungal agents.Update on terbinafine with a focus on dermatophytosesPharmacokinetics of oral terbinafine in horses and Greyhound dogs.Terbinafine: a review of its use in onychomycosis in adults.In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azolesVT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model.Efinaconazole in the treatment of onychomycosis.Prolonged Drug-Drug Interaction between Terbinafine and Perphenazine.A complex game of hide and seek: the search for new antifungalsTerbinafine: a pharmacological and clinical review.Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.Identification of FDA-approved drugs that target hepatitis B virus transcription.Terbinafine inhibits oral squamous cell carcinoma growth through anti-cancer cell proliferation and anti-angiogenesis.Physiologically based pharmacokinetic model for terbinafine in rats and humans.How effective is efinaconazole in the management of onychomycosis?Evolution of the Sterol Biosynthetic Pathway of Pythium insidiosum and Related Oomycetes Contributes to Antifungal Drug Resistance.Inhibition of human vascular endothelial cells proliferation by terbinafine.Genotoxic evaluation of terbinafine in human lymphocytes in vitro.Terbinafine in combination with other antifungal agents for treatment of resistant or refractory mycoses: investigating optimal dosing regimens using a physiologically based pharmacokinetic model.Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosisSynergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods
P2860
Q28345184-3012C308-253D-4F25-8835-0D679E61BD37Q28365213-87FEE3DA-7749-48B8-9115-8AFFBD600D16Q30881715-264C4A0E-A3CA-427D-82B2-D515D6884082Q33858325-A3BFCC26-C2AF-44FF-A165-744C7392833DQ33978865-00269E23-CA80-4833-865A-2CADFD8F075EQ34004695-071D9365-86A3-4FAE-8CBF-FE654B85F19EQ34160621-02CABF41-4D1D-4FB0-A1BC-184E2EE13FC7Q34203281-40C8B1C3-9F9B-4424-8DA0-87584F7E9C3BQ34546811-FB4C46F7-904A-47B4-9622-DCB590DD8A4FQ34620230-850B45FA-6F09-46D0-9A0D-B8B5AF6385B1Q34808217-794F2C09-2D21-4649-ACC3-CDEC1E983C00Q35023427-989E3C4B-2809-46BD-BDB1-64D3FEF30A5EQ35137828-B00C3D15-7823-4B25-B4C2-C66EDE914F43Q35168981-097F89DC-D467-49C8-B088-C4FCE0DBDDC8Q35694445-6D0CA1BE-43DA-4C36-8DF9-96FA2D369E8BQ36463532-66EC717F-80F6-47AE-A160-FA267278B196Q37344546-20F861FD-BD99-42B9-B3D7-67B0A3DEDD2FQ37623829-56CD56CE-9F64-48E7-8938-5082590971CDQ38577923-EE648013-FE59-4C24-882F-072DD9233170Q38828885-76926F9F-C22D-4096-A3DE-06916C8FBA01Q39544454-E4E18738-869D-4AC8-9710-3E26FA7BD2F3Q39652193-7A81B39E-EE8E-45AD-A04E-0C3E69E4D0F0Q40062985-8B023A9A-04E6-4CBC-A87E-BF24F78614B0Q40361138-20BDFE17-2751-4098-B4B9-84D43B39B321Q40547832-29CAB65E-4DF4-4720-BA5E-3A97E3E11DB7Q41735106-48CD4EAE-6CB9-457C-B5B9-A1A29D7C84C1Q41907385-9743B222-BE64-4506-AE06-A30D30B1C7A9Q41931602-E11C714F-685D-4B2F-82CF-3BFD1F65C912Q42708807-9BBD103C-52E5-4D6F-8CDB-28DCFF468E8E
P2860
Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites
@en
Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites.
@nl
type
label
Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites
@en
Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites.
@nl
prefLabel
Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites
@en
Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites.
@nl
P2093
P2860
P356
P1476
Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites
@en
P2093
Kovarik JM
Millerioux L
Mueller EA
Zehender H
P2860
P304
P356
10.1128/AAC.39.12.2738
P407
P577
1995-12-01T00:00:00Z